19 October, 2023
Implementing Decision by European Commission

European Commission: granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for "Oxmax - hemoglobin betafumaril (bovine)", a veterinary medicinal product

7 September, 2023
Positive Opinion by EMA/CVMP

Oxmax, the registered trade name of Oxapex in EU, received a positive opinion by EMA/CVMP in September 2023. It is indicated as an adjunct therapy in the management of haemorrhagic shock in dogs.

21 January, 2021
Oxapex launches in New Zealand

Oxapex, New Alpha Innovation’s first product, has officially launched in New Zealand.

27 October, 2020
Approval of Regulatory Updates by ACVM

Agricultural Compounds and Veterinary Medicines (ACVM) in New Zealand approved Oxapex for a Variation Application submission on October 27, 2020. Changes made to the original submission have been accepted and approved.

31 July, 2019
Change of Company Email Address

Effective 31 July 2019, our company email address has been changed from "" to "".

3 June, 2019
Change of Company Name

Effective 3 June 2019, our company name has been changed from "New A Innovation Limited" to "New Alpha Innovation Limited".
Please note that the company structure, the current contracts and agreements as well as the Chinese company name “新意康醫藥科技有限公司” remain unchanged.

23 November, 2015
US FDA Indexing

Oxapex®IDX has been added to the Index of Legally Marketed Unapproved New Animal Drugs for Minor Species at FDA.

10 June, 2015
APVMA Minor Use Permit

New Alpha Innovation receives Minor Use Permit (permit to allow supply and minor use of an unregistered veterinary chemical product) from Australian Pesticides and Veterinary Medicines Authority (APVMA) for Oxapex®.

30 August, 2012
Approval of New Drug Registration at ACVM

New Alpha Innovation receives approval of new drug registration from Agricultural Compounds and Veterinary Medicines (ACVM) in New Zealand for Oxapex®.

× We use page tagging techniques and cookies to improve the site, provide services to you, and customize your browsing experience. By continuing to browse the site you are agreeing to accept our use of cookies